Transformative all-stock transaction expected to present an estimated $200 million in run-rate cost synergiesCombined company expected to have significant financial and operating leverage with $6.5 billion in Net Revenue and $1.5 billion in Adjusted EBITDA1, including estimated synergies, for the twelve-month period ended March 31, 2024Increased presence, leading portfolio of iconic brands, diversified product offerings and enhanced distribution capabilities position the combined company for sustained long- ...